United States Biotechnology & Medical Research

Tenaya Therapeutics Inc (TNYA)

Track

Track

Tenaya Therapeutics experienced notable insider trading activity recently, with executives selling shares totaling approximately $19,886. These transactions occurred following a 17% decline in stock value over the past quarter and a negative earnings report. Leadership remains the primary source of these divestments, reflecting a cautious sentiment amidst current market performance.
Ticker: TNYA Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Tenaya Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
4.1
Ali Faraz Chief Executive Officer Executive Director
Transaction date
Sale
Price
102.81
Quantity 25,985 +9.5%
Value US$823,775
4.1
Ali Faraz Chief Executive Officer Executive Director
Transaction date
Sale
Price
471.42
Quantity 54,685 -31.4%
Value US$502,852
4.1
Ali Faraz Chief Executive Officer Executive Director
Transaction date
Sale
Price
280.57
Quantity 70,823 +33.9%
Value US$2,447,896
4.1
Ali Faraz Chief Executive Officer Executive Director
Transaction date
Sale
Price
0.71
Quantity 5,837 -1.3%
Value US$4,143
3.3
Tingley Whittemore Chief Medical Officer Officer
Transaction date
Sale
Price
0.71
Quantity 2,279 -1.1%
Value US$1,618
3.3
Tingley Whittemore Chief Medical Officer Officer
Transaction date
Sale
Price
0.71
Quantity 1,871 -0.9%
Value US$1,328
3.3
Tingley Whittemore Chief Medical Officer Officer
Transaction date
Sale
Price
0.71
Quantity 1,637 -0.7%
Value US$1,162
3.3
Tingley Whittemore Chief Medical Officer Officer
Transaction date
Planned sale
Price
0.71
Quantity 1,637 -0.7%
Value US$1,162
4.1
Faraz Ali Officer; Director Executive Director
Transaction date
Proposed sale
Price
0.71
Quantity 22,232
Value US$15,778
3.3
Whittemore Tingley Officer Officer
Transaction date
Proposed sale
Price
0.71
Quantity 7,424
Value US$5,270
3.2
Higa Tomohiro SVP, Finance Officer
Transaction date
Sale
Price
0.79
Quantity 1,485 -1.2%
Value US$1,178
3.3
Tingley Whittemore Chief Medical Officer Officer
Transaction date
Sale
Price
0.79
Quantity 3,121 -1.4%
Value US$2,477
4.1
Ali Faraz Chief Executive Officer Executive Director
Transaction date
Sale
Price
0.79
Quantity 3,390 -0.8%
Value US$2,690
2.3
COLUMN GROUP III GP, LP Large shareholder
Transaction date
Sale
Price
0.56
Quantity 1,862,545 -100.0%
Value US$1,047,495
2.3
COLUMN GROUP III GP, LP Large shareholder
Transaction date
Sale
Price
0.56
Quantity 1,649,281 -100.0%
Value US$927,556
COLUMN GROUP III, LP 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
0.60
Quantity 939,273
Value US$565,442
COLUMN GROUP III-A, LP 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
0.56
Quantity 1,060,727
Value US$596,553
2.3
COLUMN GROUP III GP, LP Large shareholder
Transaction date
Sale
Price
0.62
Quantity 349,212 -15.8%
Value US$214,870
2.3
COLUMN GROUP III GP, LP Large shareholder
Transaction date
Sale
Price
0.62
Quantity 309,228 -15.8%
Value US$190,268
2.3
COLUMN GROUP III GP, LP Large shareholder
Transaction date
Sale
Price
0.61
Quantity 277,769 -10.5%
Value US$170,800
2.3
COLUMN GROUP III GP, LP Large shareholder
Transaction date
Sale
Price
0.61
Quantity 245,965 -10.5%
Value US$151,244
COLUMN GROUP III, LP 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
0.62
Quantity 1,408,910
Value US$872,538
COLUMN GROUP III-A, LP 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
0.62
Quantity 1,591,090
Value US$985,362
3.2
Higa Tomohiro SVP, Finance Officer
Transaction date
Sale
Price
0.64
Quantity 2,022 -1.7%
Value US$1,300
3.2
Higa Tomohiro SVP, Finance Officer
Transaction date
Sale
Price
0.64
Quantity 836 -0.7%
Value US$538
3.2
Higa Tomohiro SVP, Finance Officer
Transaction date
Sale
Price
0.64
Quantity 611 -0.5%
Value US$393
3.3
Tingley Whittemore Chief Medical Officer Officer
Transaction date
Sale
Price
0.64
Quantity 1,876 -0.9%
Value US$1,206
3.3
Tingley Whittemore Chief Medical Officer Officer
Transaction date
Sale
Price
0.64
Quantity 1,642 -0.7%
Value US$1,056
3.3
Tingley Whittemore Chief Medical Officer Officer
Transaction date
Planned sale
Price
0.64
Quantity 1,642 -0.7%
Value US$1,056
4.1
Ali Faraz Chief Executive Officer Executive Director
Transaction date
Sale
Price
0.64
Quantity 5,032 -1.1%
Value US$3,236
4.1
Ali Faraz Chief Executive Officer Executive Director
Transaction date
Sale
Price
0.64
Quantity 3,979 -0.9%
Value US$2,559
4.1
Ali Faraz Chief Executive Officer Executive Director
Transaction date
Sale
Price
0.64
Quantity 5,851 -1.3%
Value US$3,762
4.1
Faraz Ali Officer; Director Executive Director
Transaction date
Proposed sale
Price
0.64
Quantity 14,862
Value US$9,557
3.3
Whittemore Tingley Officer Officer
Transaction date
Proposed sale
Price
0.64
Quantity 5,160
Value US$3,319
2.3
COLUMN GROUP III GP, LP Large shareholder
Transaction date
Sale
Price
0.68
Quantity 2,151,458 -44.8%
Value US$1,464,713
2.3
COLUMN GROUP III GP, LP Large shareholder
Transaction date
Sale
Price
0.68
Quantity 1,905,115 -44.8%
Value US$1,297,002
COLUMN GROUP III, LP 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
0.68
Quantity 657,627
Value US$446,989
COLUMN GROUP III-A, LP 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
0.68
Quantity 742,663
Value US$504,788
2.3
COLUMN GROUP III GP, LP Large shareholder
Transaction date
Sale
Price
0.82
Quantity 182,295 -3.7%
Value US$148,771
2.3
COLUMN GROUP III GP, LP Large shareholder
Transaction date
Sale
Price
0.82
Quantity 161,422 -3.7%
Value US$131,736
COLUMN GROUP III-A, LP 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
0.79
Quantity 1,591,090
Value US$1,256,961
COLUMN GROUP III, LP 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
0.79
Quantity 1,408,910
Value US$1,113,038
4.1
Ali Faraz Chief Executive Officer Executive Director
Transaction date
Sale
Price
1.33
Quantity 3,126 -1.0%
Value US$4,158
3.2
Higa Tomohiro SVP, Finance Officer
Transaction date
Sale
Price
1.33
Quantity 1,367 -1.4%
Value US$1,818
3.3
Tingley Whittemore Chief Medical Officer Officer
Transaction date
Sale
Price
1.33
Quantity 2,877 -1.7%
Value US$3,826
3.3
Whittemore Tingley Officer Officer
Transaction date
Proposed sale
Price
1.25
Quantity 5,053
Value US$6,331
4.1
Faraz Ali Officer; Director Executive Director
Transaction date
Proposed sale
Price
1.25
Quantity 14,533
Value US$18,210
3.2
Higa Tomohiro SVP, Finance Officer
Transaction date
Sale
Price
1.25
Quantity 1,722 -1.8%
Value US$2,158
3.2
Higa Tomohiro SVP, Finance Officer
Transaction date
Sale
Price
1.25
Quantity 717 -0.7%
Value US$898
3.2
Higa Tomohiro SVP, Finance Officer
Transaction date
Sale
Price
1.25
Quantity 523 -0.5%
Value US$655
3.3
Tingley Whittemore Chief Medical Officer Officer
Transaction date
Sale
Price
1.25
Quantity 1,837 -1.1%
Value US$2,302
3.3
Tingley Whittemore Chief Medical Officer Officer
Transaction date
Sale
Price
1.25
Quantity 1,608 -0.9%
Value US$2,015
3.3
Tingley Whittemore Chief Medical Officer Officer
Transaction date
Planned sale
Price
1.25
Quantity 1,608 -0.9%
Value US$2,015
4.1
Ali Faraz Chief Executive Officer Executive Director
Transaction date
Sale
Price
1.25
Quantity 4,920 -1.6%
Value US$6,165
4.1
Ali Faraz Chief Executive Officer Executive Director
Transaction date
Sale
Price
1.25
Quantity 3,893 -1.2%
Value US$4,878
4.1
Ali Faraz Chief Executive Officer Executive Director
Transaction date
Sale
Price
1.25
Quantity 5,720 -1.8%
Value US$7,167
3.3
Tingley Whittemore Chief Medical Officer Officer
Transaction date
Sale
Price
0.44
Quantity 2,937 -1.7%
Value US$1,300
4.1
Ali Faraz Chief Executive Officer Executive Director
Transaction date
Sale
Price
0.44
Quantity 3,189 -1.0%
Value US$1,412
3.2
Higa Tomohiro SVP, Finance Officer
Transaction date
Sale
Price
0.44
Quantity 1,390 -1.4%
Value US$615
3.3
Whittemore Tingley Officer Officer
Transaction date
Proposed sale
Price
0.54
Quantity 7,398
Value US$3,983
4.1
Faraz Ali Officer; Director Executive Director
Transaction date
Proposed sale
Price
0.54
Quantity 9,741
Value US$5,245
3.2
Higa Tomohiro SVP, Finance Officer
Transaction date
Sale
Price
0.54
Quantity 845 -0.8%
Value US$455
3.2
Higa Tomohiro SVP, Finance Officer
Transaction date
Sale
Price
0.54
Quantity 620 -0.6%
Value US$334
3.2
Higa Tomohiro SVP, Finance Officer
Transaction date
Sale
Price
0.54
Quantity 1,017 -1.0%
Value US$548
4.1
Ali Faraz Chief Executive Officer Executive Director
Transaction date
Sale
Price
0.54
Quantity 3,947 -1.2%
Value US$2,125
4.1
Ali Faraz Chief Executive Officer Executive Director
Transaction date
Sale
Price
0.54
Quantity 5,794 -1.8%
Value US$3,119
3.3
Tingley Whittemore Chief Medical Officer Officer
Transaction date
Sale
Price
0.54
Quantity 1,598 -0.9%
Value US$860
3.3
Tingley Whittemore Chief Medical Officer Officer
Transaction date
Sale
Price
0.54
Quantity 4,073 -2.3%
Value US$2,193
3.3
Tingley Whittemore Chief Medical Officer Officer
Transaction date
Planned sale
Price
0.54
Quantity 1,727 -0.9%
Value US$930
2.3
COLUMN GROUP III GP, LP Large shareholder
Transaction date
Purchase
Price
0.70
Quantity 35,714,284 +262.6%
Value US$24,999,999
3.8
GOEDDEL DAVID V Non-Executive Director Large shareholder
Transaction date
Purchase
Price
0.70
Quantity 35,714,284 +262.6%
Value US$24,999,999
3.7
Saito Chihiro SVP, Accounting and Fin. Ops. Officer
Transaction date
Sale
Price
2.12
Quantity 2,258 -3.6%
Value US$4,787
3.7
Saito Chihiro SVP, Accounting and Fin. Ops. Officer
Transaction date
Sale
Price
2.89
Quantity 807 -1.3%
Value US$2,336
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-17 2026-08-17 S Sale
4.1
Ali Faraz

Chief Executive Officer

Executive Director
25,985 +9.5%
102.81
US$823,775 		25,985 +9.5% 102.81 US$823,775
2026-08-17 2026-08-17 S Sale
4.1
Ali Faraz

Chief Executive Officer

Executive Director
54,685 -31.4%
471.42
US$502,852 		54,685 -31.4% 471.42 US$502,852
2026-08-17 2026-08-17 S Sale
4.1
Ali Faraz

Chief Executive Officer

Executive Director
70,823 +33.9%
280.57
US$2,447,896 		70,823 +33.9% 280.57 US$2,447,896
2026-08-17 2026-08-17 S Sale
4.1
Ali Faraz

Chief Executive Officer

Executive Director
5,837 -1.3%
0.71
US$4,143 		5,837 -1.3% 0.71 US$4,143
2026-08-17 2026-08-17 S Sale
3.3
Tingley Whittemore

Chief Medical Officer

Officer
2,279 -1.1%
0.71
US$1,618 		2,279 -1.1% 0.71 US$1,618
2026-08-17 2026-08-17 S Sale
3.3
Tingley Whittemore

Chief Medical Officer

Officer
1,871 -0.9%
0.71
US$1,328 		1,871 -0.9% 0.71 US$1,328
2026-08-17 2026-08-17 S Sale
3.3
Tingley Whittemore

Chief Medical Officer

Officer
1,637 -0.7%
0.71
US$1,162 		1,637 -0.7% 0.71 US$1,162
2026-08-17 2026-08-17 PlS Planned sale
3.3
Tingley Whittemore

Chief Medical Officer

Officer
1,637 -0.7%
0.71
US$1,162 		1,637 -0.7% 0.71 US$1,162
2026-08-17 2026-08-17 PrS Proposed sale
4.1
Faraz Ali

Officer; Director

Executive Director
22,232
0.71
US$15,778 		22,232 0.71 US$15,778
2026-08-17 2026-08-17 PrS Proposed sale
3.3
Whittemore Tingley

Officer

Officer
7,424
0.71
US$5,270 		7,424 0.71 US$5,270
2026-05-19 2026-05-18 S Sale
3.2
Higa Tomohiro

SVP, Finance

Officer
1,485 -1.2%
0.79
US$1,178 		1,485 -1.2% 0.79 US$1,178
2026-05-19 2026-05-18 S Sale
3.3
Tingley Whittemore

Chief Medical Officer

Officer
3,121 -1.4%
0.79
US$2,477 		3,121 -1.4% 0.79 US$2,477
2026-05-19 2026-05-18 S Sale
4.1
Ali Faraz

Chief Executive Officer

Executive Director
3,390 -0.8%
0.79
US$2,690 		3,390 -0.8% 0.79 US$2,690
2026-02-26 2026-02-25 S Sale
2.3
COLUMN GROUP III GP, LP
Large shareholder
1,862,545 -100.0%
0.56
US$1,047,495 		1,862,545 -100.0% 0.56 US$1,047,495
2026-02-26 2026-02-25 S Sale
2.3
COLUMN GROUP III GP, LP
Large shareholder
1,649,281 -100.0%
0.56
US$927,556 		1,649,281 -100.0% 0.56 US$927,556
2026-02-25 2026-02-25 PrS Proposed sale
COLUMN GROUP III, LP

10% Stockholder

Large shareholder
939,273
0.60
US$565,442 		939,273 0.60 US$565,442
2026-02-25 2026-02-25 PrS Proposed sale
COLUMN GROUP III-A, LP

10% Stockholder

Large shareholder
1,060,727
0.56
US$596,553 		1,060,727 0.56 US$596,553
2026-02-26 2026-02-24 S Sale
2.3
COLUMN GROUP III GP, LP
Large shareholder
349,212 -15.8%
0.62
US$214,870 		349,212 -15.8% 0.62 US$214,870
2026-02-26 2026-02-24 S Sale
2.3
COLUMN GROUP III GP, LP
Large shareholder
309,228 -15.8%
0.62
US$190,268 		309,228 -15.8% 0.62 US$190,268
2026-02-24 2026-02-23 S Sale
2.3
COLUMN GROUP III GP, LP
Large shareholder
162,291 -6.8%
0.60
US$96,920 		162,291 -6.8% 0.60 US$96,920
2026-02-24 2026-02-23 S Sale
2.3
COLUMN GROUP III GP, LP
Large shareholder
143,709 -6.8%
0.60
US$85,823 		143,709 -6.8% 0.60 US$85,823
2026-02-24 2026-02-20 S Sale
2.3
COLUMN GROUP III GP, LP
Large shareholder
277,769 -10.5%
0.61
US$170,800 		277,769 -10.5% 0.61 US$170,800
2026-02-24 2026-02-20 S Sale
2.3
COLUMN GROUP III GP, LP
Large shareholder
245,965 -10.5%
0.61
US$151,244 		245,965 -10.5% 0.61 US$151,244
2026-02-20 2026-02-20 PrS Proposed sale
COLUMN GROUP III, LP

10% Stockholder

Large shareholder
1,408,910
0.62
US$872,538 		1,408,910 0.62 US$872,538
2026-02-20 2026-02-20 PrS Proposed sale
COLUMN GROUP III-A, LP

10% Stockholder

Large shareholder
1,591,090
0.62
US$985,362 		1,591,090 0.62 US$985,362
2026-02-17 2026-02-17 S Sale
3.2
Higa Tomohiro

SVP, Finance

Officer
2,022 -1.7%
0.64
US$1,300 		2,022 -1.7% 0.64 US$1,300
2026-02-17 2026-02-17 S Sale
3.2
Higa Tomohiro

SVP, Finance

Officer
836 -0.7%
0.64
US$538 		836 -0.7% 0.64 US$538
2026-02-17 2026-02-17 S Sale
3.2
Higa Tomohiro

SVP, Finance

Officer
611 -0.5%
0.64
US$393 		611 -0.5% 0.64 US$393
2026-02-17 2026-02-17 S Sale
3.3
Tingley Whittemore

Chief Medical Officer

Officer
1,876 -0.9%
0.64
US$1,206 		1,876 -0.9% 0.64 US$1,206
2026-02-17 2026-02-17 S Sale
3.3
Tingley Whittemore

Chief Medical Officer

Officer
1,642 -0.7%
0.64
US$1,056 		1,642 -0.7% 0.64 US$1,056
2026-02-17 2026-02-17 PlS Planned sale
3.3
Tingley Whittemore

Chief Medical Officer

Officer
1,642 -0.7%
0.64
US$1,056 		1,642 -0.7% 0.64 US$1,056
2026-02-17 2026-02-17 S Sale
4.1
Ali Faraz

Chief Executive Officer

Executive Director
5,032 -1.1%
0.64
US$3,236 		5,032 -1.1% 0.64 US$3,236
2026-02-17 2026-02-17 S Sale
4.1
Ali Faraz

Chief Executive Officer

Executive Director
3,979 -0.9%
0.64
US$2,559 		3,979 -0.9% 0.64 US$2,559
2026-02-17 2026-02-17 S Sale
4.1
Ali Faraz

Chief Executive Officer

Executive Director
5,851 -1.3%
0.64
US$3,762 		5,851 -1.3% 0.64 US$3,762
2026-02-17 2026-02-17 PrS Proposed sale
4.1
Faraz Ali

Officer; Director

Executive Director
14,862
0.64
US$9,557 		14,862 0.64 US$9,557
2026-02-17 2026-02-17 PrS Proposed sale
3.3
Whittemore Tingley

Officer

Officer
5,160
0.64
US$3,319 		5,160 0.64 US$3,319
2026-02-12 2026-02-11 S Sale
2.3
COLUMN GROUP III GP, LP
Large shareholder
2,151,458 -44.8%
0.68
US$1,464,713 		2,151,458 -44.8% 0.68 US$1,464,713
2026-02-12 2026-02-11 S Sale
2.3
COLUMN GROUP III GP, LP
Large shareholder
1,905,115 -44.8%
0.68
US$1,297,002 		1,905,115 -44.8% 0.68 US$1,297,002
2026-02-11 2026-02-11 PrS Proposed sale
COLUMN GROUP III, LP

10% Stockholder

Large shareholder
657,627
0.68
US$446,989 		657,627 0.68 US$446,989
2026-02-11 2026-02-11 PrS Proposed sale
COLUMN GROUP III-A, LP

10% Stockholder

Large shareholder
742,663
0.68
US$504,788 		742,663 0.68 US$504,788
2026-02-12 2026-02-10 S Sale
2.3
COLUMN GROUP III GP, LP
Large shareholder
182,295 -3.7%
0.82
US$148,771 		182,295 -3.7% 0.82 US$148,771
2026-02-12 2026-02-10 S Sale
2.3
COLUMN GROUP III GP, LP
Large shareholder
161,422 -3.7%
0.82
US$131,736 		161,422 -3.7% 0.82 US$131,736
2026-02-10 2026-02-10 PrS Proposed sale
COLUMN GROUP III-A, LP

10% Stockholder

Large shareholder
1,591,090
0.79
US$1,256,961 		1,591,090 0.79 US$1,256,961
2026-02-10 2026-02-10 PrS Proposed sale
COLUMN GROUP III, LP

10% Stockholder

Large shareholder
1,408,910
0.79
US$1,113,038 		1,408,910 0.79 US$1,113,038
2025-11-17 2025-11-17 S Sale
4.1
Ali Faraz

Chief Executive Officer

Executive Director
3,126 -1.0%
1.33
US$4,158 		3,126 -1.0% 1.33 US$4,158
2025-11-17 2025-11-17 S Sale
3.2
Higa Tomohiro

SVP, Finance

Officer
1,367 -1.4%
1.33
US$1,818 		1,367 -1.4% 1.33 US$1,818
2025-11-17 2025-11-17 S Sale
3.3
Tingley Whittemore

Chief Medical Officer

Officer
2,877 -1.7%
1.33
US$3,826 		2,877 -1.7% 1.33 US$3,826
2025-08-18 2025-08-18 PrS Proposed sale
3.3
Whittemore Tingley

Officer

Officer
5,053
1.25
US$6,331 		5,053 1.25 US$6,331
2025-08-18 2025-08-18 PrS Proposed sale
4.1
Faraz Ali

Officer; Director

Executive Director
14,533
1.25
US$18,210 		14,533 1.25 US$18,210
2025-08-18 2025-08-18 S Sale
3.2
Higa Tomohiro

SVP, Finance

Officer
1,722 -1.8%
1.25
US$2,158 		1,722 -1.8% 1.25 US$2,158
2025-08-18 2025-08-18 S Sale
3.2
Higa Tomohiro

SVP, Finance

Officer
717 -0.7%
1.25
US$898 		717 -0.7% 1.25 US$898
2025-08-18 2025-08-18 S Sale
3.2
Higa Tomohiro

SVP, Finance

Officer
523 -0.5%
1.25
US$655 		523 -0.5% 1.25 US$655
2025-08-18 2025-08-18 S Sale
3.3
Tingley Whittemore

Chief Medical Officer

Officer
1,837 -1.1%
1.25
US$2,302 		1,837 -1.1% 1.25 US$2,302
2025-08-18 2025-08-18 S Sale
3.3
Tingley Whittemore

Chief Medical Officer

Officer
1,608 -0.9%
1.25
US$2,015 		1,608 -0.9% 1.25 US$2,015
2025-08-18 2025-08-18 PlS Planned sale
3.3
Tingley Whittemore

Chief Medical Officer

Officer
1,608 -0.9%
1.25
US$2,015 		1,608 -0.9% 1.25 US$2,015
2025-08-18 2025-08-18 S Sale
4.1
Ali Faraz

Chief Executive Officer

Executive Director
4,920 -1.6%
1.25
US$6,165 		4,920 -1.6% 1.25 US$6,165
2025-08-18 2025-08-18 S Sale
4.1
Ali Faraz

Chief Executive Officer

Executive Director
3,893 -1.2%
1.25
US$4,878 		3,893 -1.2% 1.25 US$4,878
2025-08-18 2025-08-18 S Sale
4.1
Ali Faraz

Chief Executive Officer

Executive Director
5,720 -1.8%
1.25
US$7,167 		5,720 -1.8% 1.25 US$7,167
2025-05-16 2025-05-16 S Sale
3.3
Tingley Whittemore

Chief Medical Officer

Officer
2,937 -1.7%
0.44
US$1,300 		2,937 -1.7% 0.44 US$1,300
2025-05-16 2025-05-16 S Sale
4.1
Ali Faraz

Chief Executive Officer

Executive Director
3,189 -1.0%
0.44
US$1,412 		3,189 -1.0% 0.44 US$1,412
2025-05-16 2025-05-16 S Sale
3.2
Higa Tomohiro

SVP, Finance

Officer
1,390 -1.4%
0.44
US$615 		1,390 -1.4% 0.44 US$615
2025-03-10 2025-03-10 PrS Proposed sale
3.3
Whittemore Tingley

Officer

Officer
7,398
0.54
US$3,983 		7,398 0.54 US$3,983
2025-03-10 2025-03-10 PrS Proposed sale
4.1
Faraz Ali

Officer; Director

Executive Director
9,741
0.54
US$5,245 		9,741 0.54 US$5,245
2025-03-10 2025-03-10 S Sale
3.2
Higa Tomohiro

SVP, Finance

Officer
845 -0.8%
0.54
US$455 		845 -0.8% 0.54 US$455
2025-03-10 2025-03-10 S Sale
3.2
Higa Tomohiro

SVP, Finance

Officer
620 -0.6%
0.54
US$334 		620 -0.6% 0.54 US$334
2025-03-10 2025-03-10 S Sale
3.2
Higa Tomohiro

SVP, Finance

Officer
1,017 -1.0%
0.54
US$548 		1,017 -1.0% 0.54 US$548
2025-03-10 2025-03-10 S Sale
4.1
Ali Faraz

Chief Executive Officer

Executive Director
3,947 -1.2%
0.54
US$2,125 		3,947 -1.2% 0.54 US$2,125
2025-03-10 2025-03-10 S Sale
4.1
Ali Faraz

Chief Executive Officer

Executive Director
5,794 -1.8%
0.54
US$3,119 		5,794 -1.8% 0.54 US$3,119
2025-03-10 2025-03-10 S Sale
3.3
Tingley Whittemore

Chief Medical Officer

Officer
1,598 -0.9%
0.54
US$860 		1,598 -0.9% 0.54 US$860
2025-03-10 2025-03-10 S Sale
3.3
Tingley Whittemore

Chief Medical Officer

Officer
4,073 -2.3%
0.54
US$2,193 		4,073 -2.3% 0.54 US$2,193
2025-03-10 2025-03-10 PlS Planned sale
3.3
Tingley Whittemore

Chief Medical Officer

Officer
1,727 -0.9%
0.54
US$930 		1,727 -0.9% 0.54 US$930
2025-03-07 2025-03-05 B Purchase
2.3
COLUMN GROUP III GP, LP
Large shareholder
35,714,284 +262.6%
0.70
US$24,999,999 		35,714,284 +262.6% 0.70 US$24,999,999
2025-03-07 2025-03-05 B Purchase
3.8
GOEDDEL DAVID V
Non-Executive Director Large shareholder
35,714,284 +262.6%
0.70
US$24,999,999 		35,714,284 +262.6% 0.70 US$24,999,999
2024-11-18 2024-11-18 S Sale
3.7
Saito Chihiro

SVP, Accounting and Fin. Ops.

Officer
2,258 -3.6%
2.12
US$4,787 		2,258 -3.6% 2.12 US$4,787
2024-08-19 2024-08-16 S Sale
3.7
Saito Chihiro

SVP, Accounting and Fin. Ops.

Officer
807 -1.3%
2.89
US$2,336 		807 -1.3% 2.89 US$2,336
Explore more

More insider trading research around Tenaya Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America